9 Dec 2020 11:39

Russia submits EpiVacCorona vaccine documents to WHO - Rospotrebnadzor head Popova

MOSCOW. Dec 9 (Interfax) - Documents related to the EpiVacCorona coronavirus vaccine developed by the Vector Center of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) have been submitted to the World Health Organization (WHO), Rospotrebnadzor head and Russian chief public health official Anna Popova said.

"Documents related to another Russian vaccine, EpiVacCorona, were submitted to the World Health Organization on December 8, and we are awaiting the WHO's decision," Popova said at the international scientific and practical conference on the containment of the novel coronavirus and other infectious diseases on Wednesday.

The international cooperation began in January of this year when Rospotrebnadzor 's Vector Center was included in the register of European laboratories assisting the WHO in diagnosing Covid-19 cases, Popova said.

The press service of the WHO office in Russia told Interfax earlier that the WHO invited coronavirus vaccine manufacturers on October 1, 2020, to apply for WHO evaluation (prequalification and/or listing for use in emergency situations).

The EpiVacCorona vaccine is undergoing phase 3 of clinical trials.